Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Sensus Healthcare
SRTS
Sensus Healthcare
SRTS Market Outlook
NA
NateF
Not Invested
Community Contributor
Published
04 Jan 25
Updated
07 Jan 25
43
Set Fair Value
6
votes
Share
NateF
's Fair Value
US$13.42
76.2% undervalued
intrinsic discount
07 Jan
US$3.20
Loading
1Y
-54.0%
7D
-2.1%
Author's Valuation
US$13.4
76.2% undervalued
intrinsic discount
NateF's Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
NateF
's
Fair Value
US$13.4
76.2% undervalued
intrinsic discount
Future estimation in
5 Years
time period
Past
Future
-4m
104m
2014
2017
2020
2023
2025
2026
2029
2030
Revenue US$104.5m
Earnings US$23.6m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
18.60%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.50%
Calculation
US$23.55m
Earnings '30
x
12.76x
PE Ratio '30
=
US$300.55m
Market Cap '30
US$300.55m
Market Cap '30
/
16.38m
No. shares '30
=
US$18.35
Share Price '30
US$18.35
Share Price '30
Discounted to 2025 @ 6.47% p.a.
=
US$13.41
Fair Value '25